NOAC versus warfarin in the treatment of atrial fibrillation during the first three months after bioprosthetic aortic valve replacement
Marta Piepiorka-Broniecka, Tomasz A. Michalski, Tomasz Figatowski, Andrzej Wojtowicz, Jaroslaw Jurowiecki, Aleksandra Stanska, Jan Rogowski, Milosz J. Jaguszewski
Topics & Concepts
MedicineCardiologyInternal medicineAtrial fibrillationWarfarinAortic valve replacementValve replacementAortic valveCardioversionMajor bleedingP waveCardiac Valve Diseases and TreatmentsAtrial Fibrillation Management and OutcomesInfective Endocarditis Diagnosis and Management